$25.89
1.08% today
Nasdaq, Apr 01, 06:12 pm CET
ISIN
US1572101053
Symbol
CEVA

CEVA Stock price

$25.61
-8.65 25.25% 1M
+1.46 6.05% 6M
-5.94 18.83% YTD
+2.65 11.54% 1Y
-15.04 37.00% 3Y
+0.68 2.73% 5Y
+4.29 20.12% 10Y
Nasdaq, Closing price Mon, Mar 31 2025
-0.33 1.27%
ISIN
US1572101053
Symbol
CEVA
Sector
Industry

Key metrics

Market capitalization $609.69m
Enterprise Value $451.61m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 868.48
EV/Sales (TTM) EV/Sales 4.22
P/S ratio (TTM) P/S ratio 5.70
P/B ratio (TTM) P/B ratio 2.27
Revenue growth (TTM) Revenue growth 3.68%
Revenue (TTM) Revenue $106.94m
EBIT (operating result TTM) EBIT $-8.46m
Free Cash Flow (TTM) Free Cash Flow $520.00k
Cash position $163.64m
EPS (TTM) EPS $-0.37
P/E forward negative
P/S forward 5.28
EV/Sales forward 3.91
Short interest 8.04%
Show more

Is CEVA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

CEVA Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a CEVA forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a CEVA forecast:

Buy
83%
Hold
17%

Financial data from CEVA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
107 107
4% 4%
100%
- Direct Costs 13 13
19% 19%
13%
94 94
8% 8%
87%
- Selling and Administrative Expenses 25 25
16% 16%
24%
- Research and Development Expense 72 72
4% 4%
68%
-4.32 -4.32
59% 59%
-4%
- Depreciation and Amortization 4.14 4.14
15% 15%
4%
EBIT (Operating Income) EBIT -8.46 -8.46
45% 45%
-8%
Net Profit -8.79 -8.79
26% 26%
-8%

In millions USD.

Don't miss a Thing! We will send you all news about CEVA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CEVA Stock News

Positive
Reuters
one day ago
France's Ceva Animal Health has raised 5.5 billion euros ($5.95 billion) in equity, boosting its valuation to 9.2 billion euros, as shareholders including the billionaire Bettencourt-Meyers family increased their stake, its chief executive said on Monday.
Neutral
PRNewsWire
27 days ago
The next Bluetooth® release is expected to be ratified soon. One important new feature is the Unified Test Protocol (UTP) Test Mode for Bluetooth® Low Energy, that will complement existing test methods.
Neutral
PRNewsWire
28 days ago
Leveraging Arm Neoverse CPUs, Ceva's Hardware Accelerated 5G NR Baseband Platform and SynaXG's 5G NR RAN Expertise, customized baseband processing solution delivers 10X better efficiency than traditional solutions and 20X more efficient than FPGA-based alternatives BARCELONA, Spain , March 4, 2025 /PRNewswire/ -- MWC25 -- Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software I...
More CEVA News

Company Profile

CEVA, Inc. engages in the licensing of signal processing platforms and artificial intelligence processors to chip manufacturers. Its products portfolio includes 5G mobile & infrastructure; AI & deep learning; imaging & computer vision; wireless LoT; audio, voice & speech; and sensor fusion. The company was founded on November 22, 1999 and is headquartered in Mountain View, CA.

Head office United States
CEO Amir Panush
Employees 428
Founded 1999
Website www.ceva-ip.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today